Content area

|
|

Den aktuelle globale tuberkulosesituation

Forfattere
Christian Wejse1, Troels Lillebæk2, Ole Kirk3, Pernille Ravn4, Isik Somuncu Johansen5 & Åse Bengård Andersen3, 5 1) Infektionssygdomme, Aarhus Universitetshospital 2) Nationalt Referencelaboratorium for TB & Mykobakterier, Statens Serum Institut 3) Infektionsmedicinsk Klinik, Rigshospitalet 4) Lunge- og Infektions-medicinsk Afdeling, Nordsjællands Hospital, Hillerød 5) Infektionsmedicinsk Klinik, Odense Universitetshospital Ugeskr Læger 2017;179:V12160866
Reference: 
Ugeskr Læger 2017;179:V12160866
Blad nummer: 
Sidetal: 
873-876
The current global tuberculosis state
Despite an increase in the total number of tuberculosis (TB) patients globally, positive trends in reduction of prevalence and mortality are observed. However, high numbers of drug-resistant cases are threatening this trend. Multidrug-resistant and extensively resistant cases constitute an increasing challenge in many parts of the world also within the European region – especially in former Sovjet Republic nations. Point-of-care test systems potentially replacing microscopy and urine antigen detection systems are currently launched in many TB-high endemic countries and improving TB detection rates. However, the effect on key indicators like mortality is still waiting to break through.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Tata Marion Ringberg | 18/06
4 kommentarer
af Michael Lee Heyman | 18/06
2 kommentarer
af Gitte E. Egsdal Wienholtz | 18/06
3 kommentarer
af Finn Olav Hansen | 17/06
2 kommentarer
af Morten Sodemann | 17/06
5 kommentarer